Navigation Links
PLC Systems' RenalGuard to be Demonstrated at Cardiology Meetings in Germany and Israel
Date:4/13/2012

MILFORD, Mass., April 13, 2012 /PRNewswire/ -- PLC Systems Inc. (OTC: PLCSF), a company focused on innovative medical device technologies, today announced that its innovative RenalGuard System™ is being demonstrated at two major cardiology meetings: Jahrestagung der DGK, the 78th Annual Congress of the German Society of Cardiology, April 11-14, 2012 in Mannheim, Germany, and the 59th Annual Conference of the Israel Heart Society, April 16-17, 2012 in Tel-Aviv, Israel.  Both ACIST Medical Systems, PLC's distributor in Germany, and A.M.I. Technologies, its distributor in Israel, are exhibiting RenalGuard in their booths at the events, demonstrating its ease of use along with scientific data supporting its efficacy to potential customers.  More than 8,000 clinicians and professionals are expected to attend the two conferences.

Mark R. Tauscher, president and chief executive officer of PLC Systems, said, "These conferences are premier cardiovascular events in Germany and Israel, two major new markets for RenalGuard®.  RenalGuard is being displayed in both the ACIST and A.M.I. booths at these events, providing important exposure of our new technology to global knowledge leaders, and current and potential customers."

In March 2012, A.M.I. became the exclusive distributor of RenalGuard in Israel, and secured Ministry of Health approval to market and distribute RenalGuard in the country.  In October 2011, ACIST became the exclusive distributor of PLC's RenalGuard in Germany and France, the two largest countries in the European Union. 

About PLC Systems

PLC Systems Inc., headquartered in Milford, Mass., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC's newest product, RenalGuard, has been developed to help prevent the onset of Contrast-Induced Nephropathy (CIN) in at-risk patients undergoing certain cardiac and vascular imaging procedures. The Product is CE-marked and is being marketed in Europe and selected countries around the world. Two investigator-sponsored European studies have demonstrated RenalGuard's effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by FDA.

This press release contains "forward-looking" statements. For this purpose, any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will" and similar expressions are intended to identify forward-looking statements. Our statements of our objectives are also forward-looking statements. While we may elect to update forward-looking statements in the future, we specifically disclaim any obligation to do so, even if our estimates change, and you should not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release. Actual results could differ materially from those indicated by such forward-looking statements as a result of a variety of important factors, including that we may not receive necessary regulatory approvals to market our RenalGuard product or that such approvals may be withdrawn, the U.S. clinical trial for RenalGuard may not be completed in a timely fashion, if at all, or, if this clinical trial is completed, it may not produce clinically significant or meaningful results, the RenalGuard product may not be commercially accepted, operational changes, the need for additional financing, competitive developments may affect the market for our products, regulatory approval requirements may affect the market for our products, and additional risk factors described in the "Forward Looking Statements" section of our Annual Report on Form 10-K for the year ended December 31, 2011, a copy of which is on file with the SEC.

PLC Systems, PLC Medical Systems, PLC, RenalGuard and RenalGuard Therapy are trademarks of PLC Systems Inc.

Contact:  Mary T. Conway
508-520-2545
mconway@plcmed.com 


'/>"/>
SOURCE PLC Systems Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Puritan Medical Products Company Launches New Diagnostic Collection and Transport Systems
2. Merit Medical Systems to Announce First Quarter 2012 Results on April 24, 2012
3. Berg Pharma Presents Key Findings in Cancer Systems Biology and Mitochondrial Metabolism at AACR Meeting
4. Psyche Systems Announces Availability of MicroPath, the First LIS for Microbiology
5. PLC Systems Reports Fourth Quarter and Full Year 2011 Results
6. Endo Announces Departure of American Medical Systems President
7. Frost & Sullivan: U.S. Nuclear Medicine and PET Imaging Systems Market Witnessed a Rebound in 2010, With PET Blazing the Trail
8. FDA Clears Expanded Compatibility for INOMAX® Drug-Delivery Systems
9. Psyche Systems Corporation and Aperio® Announce Availability of Their Fully Integrated Anatomic Pathology System
10. Argus Health Systems to Participate in NCPDP Focus Group
11. OxySure Systems Announces Supplier Agreement With Grainger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... April 18, 2017 Research and Markets has ... report to their offering. ... The global arthroscopy devices market to grow at a CAGR of ... Arthroscopy Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Medicine Technology:
(Date:4/28/2017)... Edinburg, Texas (PRWEB) , ... April 28, 2017 , ... ... a plaque in recently to the labor and delivery team at Women’s Hospital at ... generous mothers who give birth at the hospital and decide to donate. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... Creator responds to and which He does not. Yisrayl says with so many titles ... the true name, but he says with a little Scripture, backed with a lot of ...
(Date:4/28/2017)... ... 28, 2017 , ... NuevaCare, a leading home care agency based in San ... Alto, is proud to announce information upgrades to its blog in the form of ... on topics such as home care (generally) as well as senior care and home ...
(Date:4/27/2017)... ... 2017 , ... The Incentive Research Foundation is pleased to ... a groundbreaking analysis of how behavioral economics can be applied to the incentive, ... programs, the report highlights proven behavioral economics approaches and the powerful role emotions ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, Inc. ... at MobileIron Live! 2017 in Santa Clara, California. Each year, MobileIron ... approach to helping organizations maximize the benefits of mobility in their operations securely. ...
Breaking Medicine News(10 mins):